Cardiovascular risk assessment in inflammatory bowel disease with metabolic dysfunction-associated steatotic liver disease

Author:

García-Mateo Sandra,Martínez-Domínguez Samuel J.,Gargallo-Puyuelo Carla J.,Gallego Beatriz,Alfambra Erika,Aso María C.,Martinez-Micaelo Neus,Amigó Nuria,Martínez-García Javier,Baptista Pedro M.,Sanz Borja,Ballesta Sara,Espinosa Judith,Tejero Carlos,Gomollón Fernando

Funder

GETECCU

Publisher

Elsevier BV

Reference30 articles.

1. Comorbidities in inflammatory bowel disease: a call for action;Argollo;Lancet Gastroenterol Hepatol,2019

2. Increased risk of acute arterial events in young patients and severely active IBD: a nationwide French cohort study;Kirchgesner;Gut,2018

3. A multi-society Delphi consensus statement on new fatty liver disease nomenclature;Rinella;Hepatology,2023

4. Genetics and pathogenesis of inflammatory bowel disease;Liu;Annu Rev Pathol,2016

5. The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease;Finney;Front Cardiovasc Med,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3